Detalhe da pesquisa
1.
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
NPJ Vaccines
; 7(1): 142, 2022 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36351931
2.
Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
Antivir Ther
; 20(7): 709-19, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25318121
3.
Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Clin Ther
; 26(1): 48-62, 2004 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-14996517
4.
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
Curr Med Res Opin
; 20(5): 739-47, 2004 May.
Artigo
Inglês
| MEDLINE | ID: mdl-15140341
5.
Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis.
Ear Nose Throat J
; 82(8): 576-80, 82-4, 586 passim, 2003 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-14503094
6.
Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
South Med J
; 98(9): 863-8, 2005 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16217977
7.
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
J Antimicrob Chemother
; 54(2): 515-23, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15269191